Gurevitz Osnat, Glikson Michael
Heart Institute, Sheba Medical Center, Tel Hashomer, Israel.
Isr Med Assoc J. 2003 Aug;5(8):571-5.
CRT offers today another option for some patients with heart failure, side by side with more "traditional" therapies like drugs, assist devices, and heart transplantation. Clinical studies show that in properly selected patients a significant improvement in hemodynamic parameters and clinical status can be achieved by BV pacing. It is still unknown whether this type of therapy will also result in a survival benefit for patients with severe heart failure. The next few years certainly promise to be as exciting for CRT as were the last few.
如今，心脏再同步治疗（CRT）为一些心力衰竭患者提供了另一种选择，与药物、辅助装置和心脏移植等更“传统”的治疗方法并存。临床研究表明，在经过适当选择的患者中，通过双心室起搏可显著改善血流动力学参数和临床状况。对于重度心力衰竭患者，这种治疗方法是否也能带来生存获益仍不明确。未来几年，CRT肯定会像过去几年一样令人兴奋。
